Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Hypertension

Free Subscription 19.05.2025 6 Am J Hypertens 1 Circ Heart Fail 1 Clin Exp Hypertens 8 Hypertension 5 J Hum Hypertens 15 J Hypertens 1 J Neurosurg 4 JAMA 1 Lancet 1 PLoS Biol 8 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hypertens

1. FAN C, Wang J, Guo B, Wang S, et al
   Exploring the Causal Relationships Between Anxiety, Obesity, and Hypertension: A Two-Sample Mendelian Randomization Study.
   Am J Hypertens. 2025 May 13:hpaf072. doi: 10.1093.
   PubMed         Abstract available
   
   
2. LEE JS, Zhang YX, Wang Y, Park J, et al
   Medical Costs, Health Care Utilization, and Productivity Losses Associated with Hypertension Moderated by COVID-19 Diagnosis Among US Commercial Enrollees.
   Am J Hypertens. 2025 May 13:hpaf081. doi: 10.1093.
   PubMed         Abstract available
   
   
3. KINGUCHI S, Ishiga K, Wakui H, Azushima K, et al
   Switching From ARBs to Sacubitril/Valsartan Safely Improves 24-Hour Ambulatory Blood Pressure in Patients With Advanced Chronic Kidney Disease.
   Am J Hypertens. 2025;38:380-388.
   PubMed         Abstract available
   
   
4. FAGGIANO A, Gherbesi E, Sala C, Carugo S, et al
   Elevated Blood Pressure and Cardiac Mechanics in Children and Adolescents: A Systematic Review and Meta-Analysis.
   Am J Hypertens. 2025;38:370-379.
   PubMed         Abstract available
   
   
5. EL KHADIRI C, Bokov P, Dudoignon B, Benzouid C, et al
   Parasympathetic Modulation is Correlated With Baroreflex Sensitivity and Orthostatic Pressor Response in Childhood.
   Am J Hypertens. 2025;38:389-397.
   PubMed         Abstract available
   
   
6. TAPIA-CASTILLO A, Vecchiola A, Quinones P, Baudrand R, et al
   Primary Aldosteronism in a Hispanic Cohort: Responses to Mineralocorticoid Receptor Antagonism and Remission in a Case.
   Am J Hypertens. 2025;38:354-360.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

7. PRISCO SZ, Blake M, Kazmirczak F, Moon R, et al
   Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
   Circ Heart Fail. 2025 May 16:e012524. doi: 10.1161/CIRCHEARTFAILURE.124.012524.
   PubMed         Abstract available
   
   

   
   Clin Exp Hypertens

8. LIU X, Tan X, Su Y, Zou L, et al
   Anthocyanin attenuates pulmonary arterial hypertension and associated heart failure via improving mitochondrial function through Nrf2-dependent mechanism.
   Clin Exp Hypertens. 2025;47:2503805.
   PubMed         Abstract available
   
   

   
   Hypertension

9. BROWN JM, Tsai LC, Abel EE, Ferrebus A, et al
   Nationwide, Pragmatic, Direct-to-Patient Primary Aldosteronism Testing Program.
   Hypertension. 2025;82:977-988.
   PubMed         Abstract available
   
   
10. HAMDANI G, Urbina EM, Daniels SR, Falkner BE, et al
    Youth Blood Pressure and Target Organ Injury Markers: The SHIP AHOY Study.
    Hypertension. 2025;82:992-1001.
    PubMed         Abstract available
    
    
11. MUKKAMALA R, Shroff SG, Kyriakoulis KG, Avolio AP, et al
    Cuffless Blood Pressure Measurement: Where Do We Actually Stand?
    Hypertension. 2025;82:957-970.
    PubMed         Abstract available
    
    
12. PEWOWARUK R, Jaeger BC, Hughes TM, Upadhya B, et al
    Effects of Blood Pressure Control on Arterial Stiffness Mechanisms in SPRINT: A Randomized Controlled Trial.
    Hypertension. 2025;82:1004-1011.
    PubMed         Abstract available
    
    
13. EDWARDS JJ, Giorgione V, Griffiths M, Compton C, et al
    Cardiac Structure, Function and Mechanics in Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis.
    Hypertension. 2025 May 14. doi: 10.1161/HYPERTENSIONAHA.124.24472.
    PubMed         Abstract available
    
    
14. TOUYZ RM
    Hypertension: An Update from the Editor-in-Chief.
    Hypertension. 2025;82:927-928.
    PubMed        
    
    
15. QUARTI-TREVANO F, Seravalle G, Facchetti R, Tsioufis K, et al
    Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity.
    Hypertension. 2025;82:1024-1034.
    PubMed         Abstract available
    
    
16. BELL CS, Gidding SS
    The Morbidity of Pediatric Hypertension.
    Hypertension. 2025;82:1002-1003.
    PubMed        
    
    

    
    J Hum Hypertens

17. KARAGIANNIDIS AG, Theodorakopoulou MP, Iatridi F, Ortiz A, et al
    A salty symphony: unraveling the tale of uromodulin and sodium sensitivity.
    J Hum Hypertens. 2025;39:320-333.
    PubMed         Abstract available
    
    
18. COHEN JB, Abu Salman L, Bennett BJ, Cohen DL, et al
    Ambulatory blood pressure monitoring before and after resection of catecholamine-secreting pheochromocytoma or paraganglioma.
    J Hum Hypertens. 2025;39:369-375.
    PubMed         Abstract available
    
    
19. LEONIDOU K, Georgianos PI, Kollias A, Kontogiorgos I, et al
    Home versus routine dialysis-unit blood pressure recordings among patients on hemodialysis.
    J Hum Hypertens. 2025;39:355-361.
    PubMed         Abstract available
    
    
20. RIGLEA T, Dessy T, Kalubi J, Goulet D, et al
    Body mass index modifies genetic susceptibility to high systolic blood pressure in adolescents and young adults: results from an 18-year longitudinal study.
    J Hum Hypertens. 2025;39:334-342.
    PubMed         Abstract available
    
    
21. GREENLEES C, Delles C
    RAAS inhibitors in pregnancy, breastfeeding and women of childbearing potential: a review of national and international clinical practice guidelines.
    J Hum Hypertens. 2025;39:315-319.
    PubMed         Abstract available
    
    

    
    J Hypertens

22. PALSMA T, Claassen JAHR, Richard E, De Heus RAA, et al
    Day-to-day blood pressure variability in older persons - optimizing measurement.
    J Hypertens. 2025;43:970-975.
    PubMed         Abstract available
    
    
23. KULKARNI S, Parati G, Bangalore S, Bilo G, et al
    Blood pressure variability: a review.
    J Hypertens. 2025;43:929-938.
    PubMed         Abstract available
    
    
24. COCA A, Borghi C, Stergiou GS, Ly NF, et al
    Long-term event rates, risk factors, and treatment pattern in 1.4 million individuals qualifying for dual blood pressure lowering therapy.
    J Hypertens. 2025;43:993-1002.
    PubMed         Abstract available
    
    
25. LIP S, Tran TQB, Hanna R, Nichol S, et al
    Long-term effects of SARS-CoV-2 infection on blood vessels and blood pressure - LOCHINVAR.
    J Hypertens. 2025;43:1057-1065.
    PubMed         Abstract available
    
    
26. QIAN J, Zhou Z, Zheng Y, Rong S, et al
    Catheter-based ultrasound nerve stimulation and selective renal denervation: a preliminary case series study.
    J Hypertens. 2025;43:1083-1085.
    PubMed         Abstract available
    
    
27. GNANENTHIRAN SR, Delgado S, Mirabito Colafella KM, Schlaich MP, et al
    Changing the paradigm of long-term blood pressure control: a systematic review of novel therapies.
    J Hypertens. 2025;43:917-928.
    PubMed         Abstract available
    
    
28. COTTRELL EC
    Commentary on: "Long-term cardiovascular repercussions in women with previous pregnancies complicated by severe hypertensive disease".
    J Hypertens. 2025;43:949-950.
    PubMed        
    
    
29. HASSAN IN
    Critical appraisal of antihypertensive therapy in psoriasis: limitations and future directions.
    J Hypertens. 2025;43:1086.
    PubMed        
    
    
30. DODULIK J
    Response to Dr Hassan's letter regarding our article Pharmacotherapy of arterial hypertension in patients with psoriasis.
    J Hypertens. 2025;43:1087-1088.
    PubMed        
    
    
31. EDDISON CHUNG HUNG C, Kocherry C, George J
    Breaking down resistance: novel aldosterone synthase inhibitors in the management of resistant hypertension.
    J Hypertens. 2025 May 15. doi: 10.1097/HJH.0000000000004055.
    PubMed         Abstract available
    
    
32. STOUTENBURG EG, Bravo MC, Howard VJ, Judd SE, et al
    Factor IX and incident hypertension in Black and White adults: the REasons for Geographic and Racial Differences in Stroke cohort.
    J Hypertens. 2025 May 15. doi: 10.1097/HJH.0000000000004045.
    PubMed         Abstract available
    
    
33. DEGENAAR A, Kruger R, Jacobs A, Pieters M, et al
    Differential associations between kidney and vascular health biomarkers in young adults stratified by blood pressure status: The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension study.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004051.
    PubMed         Abstract available
    
    
34. SINGAL AM, Howard VJ, Judd SE, Carson AP, et al
    Association between serum adiponectin and risk of incident hypertension: the REGARDS study.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004057.
    PubMed         Abstract available
    
    
35. ZHANG L, Liu J
    Spironolactone protects against hypertension-induced renal fibrosis by promoting autophagy and inhibiting the NLRP3 inflammasome.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004020.
    PubMed         Abstract available
    
    
36. WANG A, Koshiaris C, Archer L, Riley RD, et al
    Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004032.
    PubMed         Abstract available
    
    

    
    J Neurosurg

37. O'LEARY S, Price A, Camarillo-Rodriguez L, Costa M, et al
    Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study.
    J Neurosurg. 2025 May 9:1-11. doi: 10.3171/2025.1.JNS242357.
    PubMed         Abstract available
    
    

    
    JAMA

38. GARRISON SR, Bakal JA, Kolber MR, Korownyk CS, et al
    Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.
    JAMA. 2025 May 12:e254390. doi: 10.1001/jama.2025.4390.
    PubMed         Abstract available
    
    
39. TALER SJ
    Morning or Nighttime Medication Dosing-Does It Matter in the Treatment of Hypertension?
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.7286.
    PubMed        
    
    
40. BROOK RD, Cohen JB, Rajagopalan S
    New Support for Old Medications in Resistant Hypertension.
    JAMA. 2025 May 14. doi: 10.1001/jama.2025.4321.
    PubMed        
    
    
41. LEE CJ, Ihm SH, Shin DH, Jeong JO, et al
    Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial.
    JAMA. 2025 May 14:e255129. doi: 10.1001/jama.2025.5129.
    PubMed         Abstract available
    
    

    
    Lancet

42. FRIEDEN TR, Garg R, Moran AE, Whelton PK, et al
    Improved hypertension care requires measurement and management in health facilities, not mass screening.
    Lancet. 2025 May 7:S0140-6736(25)00561-6. doi: 10.1016/S0140-6736(25)00561.
    PubMed         Abstract available
    
    

    
    PLoS Biol

43. YUNES-LEITES PS, Sun Y, Martinez-Martinez S, Alfayate A, et al
    Phosphatase-independent activity of smooth-muscle calcineurin orchestrates a gene expression program leading to hypertension.
    PLoS Biol. 2025;23:e3003163.
    PubMed         Abstract available
    
    

    
    PLoS One

44. GEIGER C, Cramer H, Anheyer D, Dobos G, et al
    A systematic review and meta-analysis of yoga for arterial hypertension.
    PLoS One. 2025;20:e0323268.
    PubMed         Abstract available
    
    
45. LJUBICIC M, Matek Saric M, Soric T, Saric A, et al
    The interplay between body mass index, motivation for food consumption, and noncommunicable diseases in the European population: A cross-sectional study.
    PLoS One. 2025;20:e0322454.
    PubMed         Abstract available
    
    
46. KAKCHAPATI S, Neupane R, Baral KS, Shrestha G, et al
    Social determinants and risk factors associated with non-communicable diseases among urban population in Nepal: A comparative study of poor, middle and rich wealth categories of urban population using STEPS survey.
    PLoS One. 2025;20:e0307622.
    PubMed         Abstract available
    
    
47. LAMY C, Doghri A, Costa E, Boulvain M, et al
    Hypertension as an effect modifier for preterm and small for gestational age births in migrant women in Belgium: A population-based study.
    PLoS One. 2025;20:e0323652.
    PubMed         Abstract available
    
    
48. GELETA ZM, Diriba DC, Jabana DE
    Perceived family support status and associated factors among people with hypertension in Nekemte City public hospitals, Western Ethiopia.
    PLoS One. 2025;20:e0321156.
    PubMed         Abstract available
    
    
49. AMIRUL ISLAM FM
    Study of the psychometric properties of the HLS-EU-12 questionnaire in rural Bangladesh.
    PLoS One. 2025;20:e0323608.
    PubMed         Abstract available
    
    
50. MIDDLETON RC, Karpov OA, Fournier M, Kreimer S, et al
    Impact of cardiosphere-derived cells on the maladapted right ventricular muscle in a rat sugen/hypoxia model of pulmonary hypertension with right ventricular dysfunction.
    PLoS One. 2025;20:e0321895.
    PubMed         Abstract available
    
    
51. HAILU G, Yigezu M, Gutema H, Melkamu L, et al
    Self-care practice and associated factors among hypertensive patients who have follow-ups in public hospitals of Bahir-Dar City, Northwest Ethiopia, a mixed study.
    PLoS One. 2025;20:e0317869.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.